Test group biases and ethical concerns mar New England Journal of Medicine articles promoting HPV screening for cervical cancer in rural India

CytoJournal

Volumn 6, Issue , 2009, Pages

  Austin, R ^a   Zhao, Chengquan ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CANCER STAGING; COLPOSCOPY; CYTODIAGNOSIS; HUMAN; HYSTERECTOMY; INDIA; MEDICAL ETHICS; SHORT SURVEY; UTERINE CERVIX CANCER; WART VIRUS;

EID: 77949875340     PISSN: 09745963     EISSN: 17426413     Source Type: Journal    
DOI: 10.4103/1742-6413.53466     Document Type: Short Survey

References (13)

1. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009;360:1385-94.
2. Press Release. Source: Qiagen. Landmark study in the New England Journal of Medicine shows HPV testing significantly reduces deaths from cervical cancer, compared to other methods including Pap. Wednesday April 1, 2009, 5:00 PM EDT.
3. Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS; et al. A cluster randomized controlled trial of visual, cytology, and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer 2005;116:617-23.
4. Montori VM, Guyatt GH. Intention-to-treat principle. CMAJ 2001;165:1339-41.
5. Suba EJ, Donnelly AD, Furia LM, Huynh ML, Raab SS. Cervical cancer prevention for all the world′s women: genuine promise resides in skilled quality management rather than novel screening approaches. Diagn Cytopathol 2007;35:187-91.
6. Suba EJ, Murphy SK, Donnely AD, Furia LM, Huynh LM, Raab SS. Systems analysis of real worlds obstacles to successful cervical cancer prevention in developing countries. Am J Public Health 2006;96:480-7.
7. Suba EJ, Frable WJ, Raab SS. Cost-effectiveness of cervical cancer screening in five developing countries. N Enlg J Med 2006;354:1535-6.
8. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008;26S:K29-41.
9. Schiffman M, Wacholder S. From India to the world: a better way to prevent cervical cancer. N Engl J Med 2009;360:1453-5.
10. Jaqsi R, Sheets N, Jankovic A, Motomura AR, Amarnath S, Ubel PA. Frequency, nature, effects and correlates of conflicts of interest in published Clinical Cancer Research. Cancer 2009;115:2783-91.
11. McNeil, DG. New DNA test outperforms Pap smear. New York Times. April 7, 2009.
12. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical intraepithelial neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425-34.
13. Agency for Healthcare Research and Quality. Screening for cervical cancer: File inventory. Available from: http://www.ncbi.nlm.nih.gov/books/bv. fcgi?ridhstat3.section.4193. [accessed on 2009 Apr 14].